Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

A Study of Tocilizumab in Patients With Rheumatoid Arthritis

NCT01187563 ·Status: COMPLETED

A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)

NCT01893255 ·Status: WITHDRAWN

A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis

NCT01921478 ·Status: COMPLETED

Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis

NCT02721004 ·Status: COMPLETED

A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)

NCT00106535 ·Status: COMPLETED ·Phase: PHASE3

A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

NCT01663506 ·Status: COMPLETED

Celebrex In Acute Gouty Arthritis Study

NCT00549549 ·Status: COMPLETED ·Phase: PHASE3

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

NCT01705730 ·Status: COMPLETED

A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis

NCT02309359 ·Status: COMPLETED ·Phase: PHASE2

A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis

NCT01834807 ·Status: COMPLETED

COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients

NCT04775563 ·Status: COMPLETED

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

NCT05489224 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis

NCT01462162 ·Status: COMPLETED

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01562327 ·Status: COMPLETED

An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis

NCT01741688 ·Status: COMPLETED

A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

NCT00424294 ·Status: TERMINATED ·Phase: PHASE2

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01474291 ·Status: COMPLETED

A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

NCT02046603 ·Status: COMPLETED ·Phase: PHASE3

A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis

NCT01866150 ·Status: COMPLETED

Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

NCT01481493 ·Status: COMPLETED ·Phase: PHASE2

A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs

NCT01878318 ·Status: WITHDRAWN ·Phase: PHASE4

A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

NCT01010503 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

NCT00293826 ·Status: COMPLETED ·Phase: PHASE2